{"entity":{"type":"insider","cik":"0001389208","url":"/insider/0001389208","json_url":"/insider/0001389208.json","name":"Lloyd Marcea Bland","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2012-02-24","last":"2020-07-15","span_basis":"filed_date"},"name_variants":[{"name":"Lloyd Marcea Bland","source":"filing","n_filings":3,"first_seen":"2012-02-24","last_seen":"2020-07-15"}],"transactions":[{"id":2832879,"accession":"0001209191-20-042497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-042497","line_url":"/filing/0001209191-20-042497#line-1","is_derivative":false,"issuer_cik":"0001389208","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001389208","owner_cik":"0001389208","owner_name":"Lloyd Marcea Bland","owner_display_name":"Lloyd Marcea Bland","owner_url":"/insider/0001389208","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","total_whole":"160,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-14","filed_date":"2020-07-15","scope":"insider"},{"id":3519243,"accession":"0001264124-12-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001264124-12-000081","line_url":"/filing/0001264124-12-000081#line-1","is_derivative":false,"issuer_cik":"0000881464","issuer_name":"AMYLIN PHARMACEUTICALS INC","issuer_ticker":"AMLN","issuer_name_source":null,"issuer_url":"/issuer/0000881464","owner_cik":"0001389208","owner_name":"Lloyd Marcea Bland","owner_display_name":"Lloyd Marcea Bland","owner_url":"/insider/0001389208","role":"Officer (SVP, Chief Administrative Offi), Other","role_mark":"O","role_mark_label":"Officer (SVP, Chief Administrative Offi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Administrative Offi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1846.0,"shares_display":"1,846","price_per_share":17.11,"price_display":"17.11","price_state":"stated","total_value":31585.06,"total_display":"31,585.06","total_whole":"31,585","shares_owned_after":52469.4,"shares_owned_after_display":"52,469.40","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-02","scope":"insider"},{"id":2353586,"accession":"0001264124-12-000060","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001264124-12-000060","line_url":"/filing/0001264124-12-000060#line-4","is_derivative":false,"issuer_cik":"0000881464","issuer_name":"AMYLIN PHARMACEUTICALS INC","issuer_ticker":"AMLN","issuer_name_source":null,"issuer_url":"/issuer/0000881464","owner_cik":"0001389208","owner_name":"Lloyd Marcea Bland","owner_display_name":"Lloyd Marcea Bland","owner_url":"/insider/0001389208","role":"Officer (SVP, Chief Administrative Offi)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Administrative Offi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Administrative Offi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7518.0,"shares_display":"7,518","price_per_share":17.0302,"price_display":"17.03","price_state":"stated","total_value":128033.0436,"total_display":"128,033.04","total_whole":"128,033","shares_owned_after":52043.4,"shares_owned_after_display":"52,043.40","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-24","scope":"insider"},{"id":2353581,"accession":"0001264124-12-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001264124-12-000060","line_url":"/filing/0001264124-12-000060#line-2","is_derivative":false,"issuer_cik":"0000881464","issuer_name":"AMYLIN PHARMACEUTICALS INC","issuer_ticker":"AMLN","issuer_name_source":null,"issuer_url":"/issuer/0000881464","owner_cik":"0001389208","owner_name":"Lloyd Marcea Bland","owner_display_name":"Lloyd Marcea Bland","owner_url":"/insider/0001389208","role":"Officer (SVP, Chief Administrative Offi)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Administrative Offi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Administrative Offi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5653.0,"shares_display":"5,653","price_per_share":16.6155,"price_display":"16.62","price_state":"stated","total_value":93927.4215,"total_display":"93,927.42","total_whole":"93,927","shares_owned_after":39561.4,"shares_owned_after_display":"39,561.40","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-08","filed_date":"2012-02-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001661460","name":"Poseida Therapeutics, Inc.","url":"/issuer/0001661460","role":"Director","n_filings":1,"first_seen":"2020-07-15","last_seen":"2020-07-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000881464","name":"AMYLIN PHARMACEUTICALS INC","url":"/issuer/0000881464","role":"Officer (SVP, Chief Administrative Offi), Other","n_filings":2,"first_seen":"2012-02-24","last_seen":"2012-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001389208","retrieved_at":"2026-08-24T04:46:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}